ROBERT CAMPBELL: Open Payments
NPI 1023874658 · HARTSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 83 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,060 · 2025 $1,336
Food & beverage: $1,336
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $198 |
| AstraZeneca Pharmaceuticals LP | 10 | $180 |
| Otsuka America Pharmaceutical, Inc. | 8 | $163 |
| Abbott Laboratories | 7 | $116 |
| Viatris Specialty LLC | 4 | $82 |
| Amgen Inc. | 5 | $76 |
| Novo Nordisk Inc | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 7 | $64 |
| Lilly USA, LLC | 4 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
Products named: VRAYLAR, REXULTI, FREESTYLE LIBRE 3, AIRSUPRA, YUPELRI, FARXIGA, VOQUEZNA, OTEZLA.
Industry payments across SC — which companies pay providers there.
